• Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (PubMed=9887230).
  

PubMed=1958593; DOI=10.1002/gcc.2870030406
Carol R. Bradford, Kathryn Anne Kimmel, Daniel L. Van Dyke, Maria J. Worsham, Barbara J. Tilley, David Burk, Fernando del Rosario, Stephen Lutz, Richard Tooley, Diana J.S. Hayashida, Thomas E. Carey;
11p deletions and breakpoints in squamous cell carcinoma: association with altered reactivity with the UM-E7 antibody.
Genes Chromosomes Cancer 3:272-282(1991)

PubMed=7751322; DOI=10.1007/BF01366967
Virpi Rantanen, Seija E. Grenman, Jarmo Kulmala, Reidar Grenman;
The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay.
J. Cancer Res. Clin. Oncol. 121:230-234(1995)

PubMed=9887230; DOI=10.1006/gyno.1998.5194
Virpi Rantanen, Seija E. Grenman, Kaisa Kurvinen, Sakari H. Hietanen, Misa Raitanen, Stina M. Syrjanen;
p53 mutations and presence of HPV DNA do not correlate with radiosensitivity of gynecological cancer cell lines.
Gynecol. Oncol. 71:352-358(1998)

PubMed=28236344; DOI=10.1002/hed.24729; PMCID=PMC5392184
Heather M. Walline, Christine Marie Goudsmit, Jonathan B. McHugh, Alice L. Tang, John Henry Owen, Bin Tean Teh, Erin L. McKean, Thomas W. Glover, Martin P. Graham, Mark Edward P. Prince, Douglas Brian Chepeha ...Show all 19 authors... , Steven B. Chinn, Robert Louis Ferris, Susanne M. Gollin, Thomas K. Hoffmann, Henning Bier, Ruud H. Brakenhoff, Carol R. Bradford, Thomas E. Carey; Show fewer authors
University of Michigan Head and Neck Specialized Program of Research Excellence (SPORE) Program
Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines.
Head Neck 39:840-852(2017)